Literature DB >> 32562615

Replacing cART with CAR-T Cells: Using Immunotherapy to Cure HIV.

Sarah E Beck1, Joel N Blankson2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32562615      PMCID: PMC7335749          DOI: 10.1016/j.ymthe.2020.06.008

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

1.  Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

Authors:  Rebecca T Veenhuis; Abena K Kwaa; Caroline C Garliss; Rachel Latanich; Maria Salgado; Christopher W Pohlmeyer; Christopher L Nobles; John Gregg; Eileen P Scully; Justin R Bailey; Frederic D Bushman; Joel N Blankson
Journal:  JCI Insight       Date:  2018-09-20

2.  Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases.

Authors:  Timothy J Henrich; Emily Hanhauser; Francisco M Marty; Michael N Sirignano; Sheila Keating; Tzong-Hae Lee; Yvonne P Robles; Benjamin T Davis; Jonathan Z Li; Andrea Heisey; Alison L Hill; Michael P Busch; Philippe Armand; Robert J Soiffer; Marcus Altfeld; Daniel R Kuritzkes
Journal:  Ann Intern Med       Date:  2014-09-02       Impact factor: 25.391

3.  Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.

Authors:  R T Mitsuyasu; P A Anton; S G Deeks; D T Scadden; E Connick; M T Downs; A Bakker; M R Roberts; C H June; S Jalali; A A Lin; R Pennathur-Das; K M Hege
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

4.  Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

Authors:  R E Walker; C M Bechtel; V Natarajan; M Baseler; K M Hege; J A Metcalf; R Stevens; A Hazen; R M Blaese; C C Chen; S F Leitman; J Palensky; J Wittes; R T Davey; J Falloon; M A Polis; J A Kovacs; D F Broad; B L Levine; M R Roberts; H Masur; H C Lane
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

5.  A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

Authors:  Steven G Deeks; Bridget Wagner; Peter A Anton; Ronald T Mitsuyasu; David T Scadden; Christine Huang; Catherine Macken; Douglas D Richman; Cindy Christopherson; Carl H June; Richard Lazar; David F Broad; Sayeh Jalali; Kristen M Hege
Journal:  Mol Ther       Date:  2002-06       Impact factor: 11.454

6.  Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus.

Authors:  George J Leslie; Jianbin Wang; Max W Richardson; Beth S Haggarty; Kevin L Hua; Jennifer Duong; Anthony J Secreto; Andrea P O Jordon; Josephine Romano; Kritika E Kumar; Joshua J DeClercq; Philip D Gregory; Carl H June; Michael J Root; James L Riley; Michael C Holmes; James A Hoxie
Journal:  PLoS Pathog       Date:  2016-11-17       Impact factor: 6.823

7.  HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo.

Authors:  Colby R Maldini; Kevin Gayout; Rachel S Leibman; Derrick L Dopkin; Joshua P Mills; Xiaochuan Shan; Joshua A Glover; James L Riley
Journal:  Mol Ther       Date:  2020-05-15       Impact factor: 11.454

Review 8.  Targeting the Latent Reservoir for HIV-1.

Authors:  Srona Sengupta; Robert F Siliciano
Journal:  Immunity       Date:  2018-05-15       Impact factor: 31.745

9.  HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.

Authors:  Timothy J Henrich; Hiroyu Hatano; Oliver Bacon; Louise E Hogan; Rachel Rutishauser; Alison Hill; Mary F Kearney; Elizabeth M Anderson; Susan P Buchbinder; Stephanie E Cohen; Mohamed Abdel-Mohsen; Christopher W Pohlmeyer; Remi Fromentin; Rebecca Hoh; Albert Y Liu; Joseph M McCune; Jonathan Spindler; Kelly Metcalf-Pate; Kristen S Hobbs; Cassandra Thanh; Erica A Gibson; Daniel R Kuritzkes; Robert F Siliciano; Richard W Price; Douglas D Richman; Nicolas Chomont; Janet D Siliciano; John W Mellors; Steven A Yukl; Joel N Blankson; Teri Liegler; Steven G Deeks
Journal:  PLoS Med       Date:  2017-11-07       Impact factor: 11.069

10.  Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection.

Authors:  Donn J Colby; Lydie Trautmann; Suteeraporn Pinyakorn; Louise Leyre; Amélie Pagliuzza; Eugène Kroon; Morgane Rolland; Hiroshi Takata; Supranee Buranapraditkun; Jintana Intasan; Nitiya Chomchey; Roshell Muir; Elias K Haddad; Sodsai Tovanabutra; Sasiwimol Ubolyam; Diane L Bolton; Brandie A Fullmer; Robert J Gorelick; Lawrence Fox; Trevor A Crowell; Rapee Trichavaroj; Robert O'Connell; Nicolas Chomont; Jerome H Kim; Nelson L Michael; Merlin L Robb; Nittaya Phanuphak; Jintanat Ananworanich
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

View more
  1 in total

Review 1.  CAR T cells: Building on the CD19 paradigm.

Authors:  Anat Globerson Levin; Isabelle Rivière; Zelig Eshhar; Michel Sadelain
Journal:  Eur J Immunol       Date:  2021-08-02       Impact factor: 6.688

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.